Antibodies targeting ABCG transporters are critical for functional studies. While ABCG40-specific antibodies are not explicitly detailed, analogous antibodies (e.g., anti-ABCG2, anti-ABCG25) provide a framework:
ATPase activity: ABCG transporters exhibit intrinsic ATP hydrolysis. For example, ABCC4 shows higher ATPase activity than CFTR, with mutations (e.g., Q413A) impairing function .
Pathological relevance: ABCG2 overexpression correlates with chemoresistance in cancer, while ABCG25 mutations disrupt ABA signaling in plants .
Epitope specificity: Antibodies must distinguish between homologous ABCG members (e.g., ABCG40 vs. ABCG30/31) .
Validation criteria: Include knockout controls, cross-reactivity screens, and functional assays (e.g., transport inhibition) .